Versant Ventures - aVenture Asset Manager Research
Location
San Francisco, CA, US
Founded
1999
Versant Ventures is a prominent healthcare investment firm specializing in biotechnology companies that focus on discovering and developing novel therapeutics. With $2.4 billion under management, the firm typically invests in early to mid-stage rounds, including Series A, B, and C. Versant Ventures operates globally with multiple locations and has a strong emphasis on leveraging scientific advancements to drive innovation in healthcare.
Notable portfolio companies include Century Therapeutics, Black Diamond Therapeutics, and Gritstone bio. The firm boasts an experienced team with extensive backgrounds in venture capital, pharmaceuticals, and biotechnology. Versant Ventures offers unique value-add services through its Discovery Engines, which consist of in-house teams of multi-disciplinary scientists working in state-of-the-art laboratory facilities to support the launch of novel biotech ventures.
Versant Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
